SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-23-237903
Filing Date
2023-09-20
Accepted
2023-09-19 21:57:58
Documents
9
Effectiveness Date
2023-09-20

Document Format Files

Seq Description Document Type Size
1 S-8 d481326ds8.htm S-8 66257
2 EX-5.1 d481326dex51.htm EX-5.1 12518
3 EX-23.2 d481326dex232.htm EX-23.2 1849
4 EX-99.1(A) d481326dex991a.htm EX-99.1(A) 90962
5 EX-99.1(B) d481326dex991b.htm EX-99.1(B) 55659
6 EX-99.3A d481326dex993a.htm EX-99.3A 128843
7 EX-99.4 d481326dex994.htm EX-99.4 87102
8 EX-FILING FEES d481326dexfilingfees.htm EX-FILING FEES 27742
9 GRAPHIC g481326dsp0039.jpg GRAPHIC 4040
  Complete submission text file 0001193125-23-237903.txt   477752
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

IRS No.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-274593 | Film No.: 231265202
SIC: 2836 Biological Products, (No Diagnostic Substances)